India to Netherlands: Trastuzumab Export Trade Route

The India to Netherlands Trastuzumab corridor is one of India's established pharmaceutical export routes, with 225 shipments documented worth a combined $29.3M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 96% of all export value, reflecting the consolidated nature of India's trastuzumab manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $130.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with trastuzumab's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 22.8%, placing it at rank #13 among India's top trastuzumab export destinations globally.

On the import side, key buyers of Indian trastuzumab in Netherlands include MYLAN IRELAND LIMITED, BIOSIMILAR COLLABORATIONS IRELAND L, MYLAN IRELAND LTD and 4 others. MYLAN IRELAND LIMITED is the single largest importer with 108 shipments valued at $12.6M USD.

India's trastuzumab exports to Netherlands are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 211 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Netherlands benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED, MYLAN LABORATORIES LIMITED , BIOCON BIOLOGICS INDIA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $130.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as trastuzumab lyophilized powder for injection rdna origin 150 mg batch no 7802591 and trastuzumab lyophilized powder for injection rdna origin 150 mg batch no 3235305, suggesting that buyers in Netherlands tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MYLAN IRELAND LIMITED is the largest importer with 108 shipments worth $12.6M USD — representing 43% of all trastuzumab imports from India on this route. A total of 7 buyers are active on this corridor.